Bard Peripheral Vascular Inc recalls EnCor Breast Biopsy Probes, packaged individually in sterile pouches, 5 pouches/carton, single use, Rx, catalog/REF num…
- Recall date
- May 2, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-2209-2019
- FDA classification
- Class II
- Brand / firm
- Bard Peripheral Vascular Inc
- Sold / distributed
- Worldwide distribution - US Nationwide distribution, including Puerto Rico. There was government and foreign distribution and no military distribution. Foreign distribution was made to Canada, Algeria, Australia, Austria, Belgium, Chile, China, Colombia, Croatia, Cyprus, Czech Republic, Denmark, Eg…
Why it was recalled
There has been an increase in complaints related to leaks, suction issues, and failure to obtain samples while using the product.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
EnCor Breast Biopsy Probes, packaged individually in sterile pouches, 5 pouches/carton, single use, Rx, catalog/REF number 10G - REF ECP0110G. Product Usage: Indicated for use in acquiring tissue for diagnosing breast abnormalities.
Get recall alerts
Free email alert whenever Bard Peripheral Vascular Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Bard Peripheral Vascular Inc